Carbon-nanotube EUV pellicles are moving into production equipment
Finland, South Korea, Japan and Global
Share ↗
The signal
A repeat reactor order in Finland and South Korea, a Korean startup's dedicated customer-evaluation line, and Japanese incumbent investment in CNT pellicle capacity indicate that carbon-nanotube membranes are moving from materials research toward a multi-supplier production ecosystem for advanced lithography.
The clue
Carbon-nanotube membranes intended to protect semiconductor photomasks are progressing from research into reactors, production lines and customer qualification.
Why it matters
As extreme-ultraviolet lithography operates at higher power, the pellicle protecting each mask must transmit light, tolerate heat and avoid introducing defects. This could create a specialized materials and equipment category upstream of advanced chip production.
Evidence and interpretation
- Observed facts: Finland’s Canatu received a repeat order worth more than €5 million for CNT pellicle-manufacturing equipment from South Korea’s FST. Korean startup aweXome Ray reports a dedicated clean-room line and ongoing customer evaluations. Mitsui Chemicals has disclosed investment in Japanese CNT-pellicle mass-production facilities. - Interpretation: Orders from an established component manufacturer, startup capacity and incumbent investment support a broader supplier pattern—not a prediction based on one laboratory result. - Alternatives globally: Conventional silicon-based pellicles may remain sufficient for some lithography systems. Manufacturers can also improve cooling, operate without pellicles in limited circumstances or pursue other heat-resistant membrane materials. - Speculation: Reactor equipment, licensed production methods and proprietary consumables may become recurring businesses around CNT pellicles.
What to watch next
The thesis strengthens if fabs complete qualification, reactor orders convert into royalty-bearing production, membrane lifetime and transmission hold at higher EUV power, and more than one supplier ships volume; it weakens if qualification slips, defect rates remain high, or conventional pellicles and pellicle-free operation remain adequate.